Publications by authors named "Kelly Waldeck"

Claim this Profile
A
A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to Lutetium-DOTA-octreotate radionuclide therapy.
Kelly Waldeck, Jessica Van Zuylekom, Carleen Cullinane, Twishi Gulati, Kaylene J Simpson

Theranostics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival.
Nicholas A Gherardin, Kelly Waldeck, Alex Caneborg, Luciano G Martelotto, Shiva Balachander

Cancer Immunol Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer.
Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, Kelly Waldeck, Peter D Roselt

J Med Chem· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the anti-tumour activity of Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP.
Carleen Cullinane, Kelly Waldeck, Laura Kirby, Buck E Rogers, Peter Eu

Sci Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention.
Nicholas A Zia, Carleen Cullinane, Jessica K Van Zuylekom, Kelly Waldeck, Lachlan E McInnes

Angew Chem Int Ed Engl· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance.
Claire A Martin, Carleen Cullinane, Laura Kirby, Shatha Abuhammad, Emily J Lelliott, Kelly Waldeck

Int J Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model.
Kelly Waldeck, Carleen Cullinane, Kerry Ardley, Jake Shortt, Ben Martin

Int J Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate.
Michelle T Ma, Carleen Cullinane, Kelly Waldeck, Peter Roselt, Rodney J Hicks

EJNMMI Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
Stephen Q Wong, Kelly Waldeck, Ismael A Vergara, Jan Schröder, Jason Madore

Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genomic landscape of phaeochromocytoma.
Aidan Flynn, Diana Benn, Roderick Clifton-Bligh, Bruce Robinson, Alison H Trainer, Kelly Waldeck

J Pathol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside.
Jeremy Lewin, Carleen Cullinane, Tim Akhurst, Kelly Waldeck, D Neil Watkins

Eur J Nucl Med Mol Imaging· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.
Richard J Young, Kelly Waldeck, Claire Martin, Jung H Foo, Donald P Cameron

Pigment Cell Melanoma Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901.
Carleen Cullinane, Kelly L Waldeck, David Binns, Ekaterina Bogatyreva, Daniel P Bradley

Nucl Med Biol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence.
Meaghan Wall, Gretchen Poortinga, Kym L Stanley, Ralph K Lindemann, Michael Bots, Kelly Waldeck

Cancer Discov· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer.
Delphine Denoyer, Laura Kirby, Kelly Waldeck, Peter Roselt, Oliver C Neels

Eur J Nucl Med Mol Imaging· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
Richard J Young, Danny Rischin, Richard Fisher, Grant A McArthur, Stephen B Fox, Kelly Waldeck

Cancer Epidemiol Biomarkers Prev· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor model.
Nicolas Aide, Kathryn Kinross, Carleen Cullinane, Peter Roselt, Kelly Waldeck

J Nucl Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
John T Price, Julian M W Quinn, Natalie A Sims, Jessica Vieusseux, Kelly Waldeck

Cancer Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis